TABLE 1. Adverse event reports for adolescents aged 12–17 years who received the Pfizer-BioNTech COVID-19 vaccine, by demographic characteristics and reported symptoms (N = 9,246) — Vaccine Adverse Event Reporting System, United States, December 14, 2020–July 16, 2021.
| Characteristic | Total, % (N = 9,246) | Severity, %* |
||
|---|---|---|---|---|
| Nonserious (n = 8,383) | Serious, excluding death (n = 849) | Death (n = 14) | ||
|
Sex
| ||||
| Female |
52.9 |
55.3 |
29.1 |
35.7 |
| Male |
45.8 |
43.2 |
70.7 |
64.3 |
| Unknown |
1.4 |
1.5 |
0.2 |
0 |
|
Age group, yrs
| ||||
| 12–15 |
58.1 |
58.7 |
53.4 |
28.6 |
| 16–17 |
41.9 |
41.3 |
46.6 |
71.4 |
|
Ethnicity
| ||||
| Hispanic or Latino |
10.4 |
9.6 |
18.4 |
7.1 |
| Non-Hispanic or Latino |
44.1 |
43.4 |
51.2 |
50.0 |
| Unknown ethnicity |
45.5 |
47.1 |
30.4 |
42.9 |
|
Race
| ||||
| American Indian or Alaska Native |
0.8 |
0.8 |
0.5 |
0 |
| Asian |
5.2 |
5.0 |
7.3 |
7.1 |
| Black |
3.2 |
3.0 |
5.3 |
7.1 |
| Native Hawaiian or Pacific Islander |
0.3 |
0.2 |
0.7 |
0 |
| White |
45.1 |
44.2 |
53.8 |
71.4 |
| Multiracial |
2.1 |
2.2 |
2.0 |
0 |
| Other |
13.1 |
13.9 |
5.4 |
0 |
| Unknown race | 30.2 | 30.8 | 25.0 | 14.3 |
Abbreviation: VAERS = Vaccine Adverse Event Reporting System.
* VAERS reports are classified as serious if any of the following are reported: hospitalization or prolongation of hospitalization, life-threatening illness, permanent disability, congenital anomaly or birth defect, or death.